Sansure Biotech (SHSE:688289) Change In Receivables : ¥0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Sansure Biotech Change In Receivables?

Sansure Biotech's change in receivables for the quarter that ended in Mar. 2024 was ¥0 Mil. It means Sansure Biotech's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Sansure Biotech's change in receivables for the fiscal year that ended in Dec. 2023 was ¥377 Mil. It means Sansure Biotech's Accounts Receivable declined by ¥377 Mil from Dec. 2022 to Dec. 2023 .

Sansure Biotech's Accounts Receivable for the quarter that ended in Mar. 2024 was ¥662 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Sansure Biotech's Days Sales Outstanding for the three months ended in Mar. 2024 was 154.41.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Sansure Biotech's liquidation value for the three months ended in Mar. 2024 was ¥4,421 Mil.

Sansure Biotech Change In Receivables Historical Data

The historical data trend for Sansure Biotech's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sansure Biotech Change In Receivables Chart

Sansure Biotech Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-33.76

-419.38

-304.14

-496.51

376.54

Sansure Biotech Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Sansure Biotech Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Sansure Biotech (SHSE:688289) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Sansure Biotech's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	661.552	/	390.947	*	91
=	154.41

2. In Ben Graham's calculation of liquidation value, Sansure Biotech's accounts receivable are only considered to be worth 75% of book value:

Sansure Biotech's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	4948.031	-	1216.441	+	0.75 * 661.552	+	0.5 * 385.497
=	4,421

Sansure Biotech Change In Receivables Related Terms

Thank you for viewing the detailed overview of Sansure Biotech's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Sansure Biotech (SHSE:688289) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sansure Biotech Inc (SHSE:688289) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 680, Lusong Road, Changsha High-tech Industrial Development Zone, Hunan Province, Changsha, CHN, 410205

Website

http://www.sansure.com.cn

Sansure Biotech Inc is engaged in production and sales of diagnostic reagents and instruments. The company produces Class I medical devices, Class II medical devices, Class III medical devices, general instruments and meters, medical raw materials, medical laboratory equipment and appliances, and medical accessories.

Sansure Biotech (SHSE:688289) Headlines

No Headlines